This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Vitamin K2 and nocturnal cramps

Authoring team

Vitamin K can be divided into vitamins K1, K2, K3, K4 and K5 (1):

  • the two major subtypes are vitamin K1 and K2, whereas vitamin K3 is a synthetic form which can be converted to vitamin K2 in vivo

A pilot trial demonstrated that vitamin K2 supplementation could decrease the frequency, duration, and severity of muscle cramps in haemodialysis patients (2).

A randomized clinical trial involving 199 participants 65 years and older with nocturnal leg cramps, those who received vitamin K2 experienced a significant reduction in the mean frequency of cramps per week compared with the placebo group (3).

Reference:

  1. Khalil Z et al. The Medical Benefits of Vitamin K2 on Calcium-Related Disorders. Nutrients. 2021 Feb 21;13(2):691
  2. Xu D et al. Vitamin K2 as a potential therapeutic candidate for the prevention of muscle cramps in hemodialysis patients: A prospective multicenter, randomized, controlled, crossover pilot trial. Nutrition. 2022 May;97:111608.
  3. Tan J, Zhu R, Li Y, et al. Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial. JAMA Intern Med. Published online October 28, 2024.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.